Leave feedback

2-chloro-4-(piperazin-1-yl)pyrimidine



Compound number:
MolPort-000-002-926
CAS number: 174728-03-1
IUPAC:
2-chloro-4-(piperazin-1-yl)pyrimidine
IUPAC traditional:
2-chloro-4-(piperazin-1-yl)pyrimidine
SMILES:
Clc1nccc(n1)N1CCNCC1
InChI key:
SFYYCOYORWAGQC-UHFFFAOYSA-N
Molecular formula:
C8H11ClN4
Molecular weight: 198.65
Solubility: not available

Marketplace Offers

Direct S&H to USA: 95.00 USD
Direct S&H to World: 65.00 USD

During check-out process you will be able to choose between:
  - Consolidated MolPort Shipping
  - Direct Shipping

Supplier Catalogue Data


Catalog: Screening compound Ships out: 12 business days Purity: 95.00
Last updated: last month In warehouse: 700.00 mg
Pack size Ships out Price Qty
1 mg July 1, 2021 39.00 USD
ADD TO CART
5 mg July 1, 2021 59.00 USD
ADD TO CART
10 mg July 1, 2021 69.00 USD
ADD TO CART

More Information

Compound Identifiers
Compound number: MolPort-000-002-926
CAS number: 174728-03-1

Names, Synonyms and 3rd Party Identifiers
Name: ZINC000003716156
2-Chloro-4-piperazin-1-yl-pyrimidine
pyrimidine, 2-chloro-4-(1-piperazinyl)-
MFCD05182232

InChI
InChI: 1S/C8H11ClN4/c9-8-11-2-1-7(12-8)13-5-3-10-4-6-13/h1-2,10H,3-6H2
InChI key: SFYYCOYORWAGQC-UHFFFAOYSA-N

Calculated Properties
Molecular formula: C8H11ClN4
Molecular weight: 198.65

Scaffolds

Other

Sales contact

+1 (215) 9991090

+371 67881775

sales@molport.com


At MolPort, we welcome your thoughts, comments, questions and feedback. Our customer services department will be happy to help you Monday to Friday 7 a.m. to 4 p.m. GMT (2 a.m. - 10 a.m. EST).
Exceptions - closed on national holidays in Latvia (headquarters).


2021 MolPort, v4.77, release date 13-06-2021 13:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.